PCSK9
前蛋白转化酶
可欣
低密度脂蛋白受体
前蛋白转化酶类
枯草杆菌素
临床试验
药理学
化学
胆固醇
医学
脂蛋白
生物化学
内科学
酶
作者
Enrico Mario Alessandro Fassi,Andrea Citarella,Marco Albani,Erica Ginevra Milano,Laura Legnani,Carmen Lammi,Alessandra Silvani,Giovanni Grazioso
标识
DOI：10.1080/13543776.2024.2340569
摘要
Proprotein convertase subtilisin/kexin 9 (PCSK9) plays a crucial role in breaking down the hepatic low-density lipoprotein receptor (LDLR), thereby influencing the levels of circulating low-density lipoprotein cholesterol (LDL-C). Consequently, inhibiting PCSK9 through suitable ligands has been established as a validated therapeutic strategy for combating hypercholesterolemia and cardiovascular diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI
SYLH
科研助手6
昏睡的蟠桃
nozero
cdercder
卡卡西
妞妞公主喜欢派大星
猪猪hero
bc
带头大哥
彭于彦祖
HEIKU
平常的毛豆
冰魂
iNk
粗心的绾绾
pcr163
Billy
子车茗
HEAUBOOK
皖公网安备34019202002308
